| 杜绣琳.长期使用质子泵抑制剂对老年患者骨代谢和骨密度的影响[J].安徽医药,2018,22(3):510-513. |
| 长期使用质子泵抑制剂对老年患者骨代谢和骨密度的影响 |
| Effects of long-term use of proton pump inhibitors on bone metabolism and bone mineral density in elderly patients |
| 投稿时间：2017-02-06 |
| DOI： |
| 中文关键词: 质子泵抑制剂 骨代谢 骨密度 老年患者 |
| 英文关键词: proton pump inhibitor bone metabolism bone mineral density elderly patients |
| 基金项目:上海市医院药学科研基金项目(2013-YY-02-02) 长期使用质子泵抑制剂对老年患者骨代谢和骨密度的影响杜绣琳 (上海邮电医院药剂科,上海 200040) 长期使用质子泵抑制剂对老年患者骨代谢和骨密度的影响杜绣琳 Effects of long-term use of proton pump inhibitors on bone metabolism and bone mineral density in elderly patients DU Xiulin |
|
| 摘要点击次数: 2180 |
| 全文下载次数: 598 |
| 中文摘要: |
| 目的 探讨长期使用质子泵抑制剂对老年患者骨代谢和骨密度的影响。 方法 连续收集因反流性食管炎需要长期服用质子泵抑制剂的老年患者50例作为观察组,同期收集50例健康老年人作为对照组。比较两组的骨密度和骨代谢情况。 结果 入组时,两组患者股骨颈骨密度差异无统计学意义(0.80±0.10 vs 0.79±0.09 g·cm-2,P=0.708)。3个月和6个月时,观察组股骨颈骨密度均显著低于对照组[(0.73±0.10 vs 0.82±0.09 g·cm-2,P=0.000)和(0.68±0.11 vs 0.79±0.09 g·cm-2,P=0.000)]。两组研究对象入组时降钙素、骨钙素、碱性磷酸酶和Ⅰ型胶原羧基末端肽均差异无统计学意义(P>0.05)。6个月时,观察组降钙素、骨钙素和碱性磷酸酶均显著低于对照组[(221.87±68.82 vs 251.53±58.72 ng·L-1,P=0.023)、(9.82±2.56 vs 11.66±2.88 μg·L-1,P=0.001)、(10.47±2.18 vs 12.66±1.75 μg·L-1,P=0.000)],Ⅰ型胶原羧基末端肽显著高于对照组(253.85±51.66 vs 225.39±52.88 ng·L-1,P=0.008)。 结论 长期使用质子泵抑制剂可导致骨破坏增加,进而导致骨质疏松。 |
| 英文摘要: |
| Objective To investigate the effects of long-term use of proton pump inhibitors on bone metabolism and bone mineral density in elderly patients. Methods 50 elderly patients with reflux esophagitis who required long-term use of proton pump inhibitors were collected as the observation group,while 50 healthy elderly people were collected as the control group.Bone mineral density and bone metabolism were compared between the two groups. Results There was no significant difference in bone mineral density of neck of femur (0.80±0.10 vs 0.79±0.09 g·cm-2,P =0.708).At 3 months and 6 months after treatment,the bone mineral density of neck of femur in the observation group was lower than that in the control group [(0.73±0.10 vs 0.82±0.09 g·cm-2,P =0.000) and (0.68±0.11 vs 0.79±0.09 g·cm-2,P=0.000)].There were no significant differences between the two groups in calcitonin,osteocalcin,alkaline phosphatase and collagen carboxy terminal peptide of type Iwhen admission (P >0.05).At 6 months later,compared with the control group,the levels of calcitonin,osteocalcin,alkaline phosphatase [(221.87±68.82 vs 251.53±58.72 ng·L-1,P=0.023),(9.82±2.56 vs 11.66±2.88 μg·L-1,P=0.001),(10.47±2.18 vs 12.66±1.75 μg·L-1,P=0.000)] in the observation group were decreased,but the level of collagen carboxy terminal peptide of type I (253.85±51.66 vs 225.39±52.88 ng·L-1,P=0.008) was increased. Conclusions Long-term use of proton pump inhibitors can lead to increased bone destruction,which results in the development of osteoporosis. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
